Share This

Public company info - Lansen Pharmaceutical Holdings Ltd. , 00503.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Lansen Pharmaceutical Holdings Ltd., 00503.HK - Cash Flow 2022-12 2021-12 2020-12 2019-12 2018-12 2017-12 2016-12 2015-12 2014-12 2013-12 2012-12 2011-12 2010-12 2009-12 2008-12 2007-12
Net Cash Flow from Operating Activities 20,972 13,461 24,106 11,327 8,670 16,155 2,162 11,943 17,423 9,185 11,101 7,140 1,852 6,006 4,779 3,565
Net Cash Flow from Return on Investments & Servicing of Finance -214 -76,808 -974 -4,309 -6,973 -15,206 -7,314 -7,565 -10,510 -10,813 -5,613 -10,104 -5,713 -3,720 -4,147 -654
　Interest Received 875 1,470 558 454 466 595 558 811 452 417 288 204 109 247 288 120
　Interest Paid -1,089 -1,469 -1,991 -4,252 -4,118 -3,908 -3,311 -3,376 -2,972 -1,733 -1,313 -522 -432 -667 -1,518 -774
　Dividend Received 0 56 459 1,344 122 225 796 1,517 836 426 4,174 359 0 0 0 0
　Dividend Paid 0 -76,865 0 -1,855 -3,443 -12,118 -5,357 -6,517 -8,826 -9,923 -8,762 -10,145 -5,390 -3,300 -2,917 0
　Others 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Taxes (Paid) / Refunded -1,771 -2,975 -2,416 -154 -1,991 -1,693 -2,552 -2,065 -2,758 -3,126 -2,903 -2,752 -1,683 -1,192 -774 -188
Net Cash Flow from Investing Activities 2,946 28,629 73,218 30,821 12,649 8,133 -18,291 -5,415 -25,142 -12,169 -20,547 -11,583 -27,588 -5,510 3,512 -10,625
　Additions to Fixed Assets -603 -678 -718 -1,367 -1,742 -2,204 -2,396 -3,685 -2,758 -6,355 -7,767 -3,192 -3,368 -4,714 -862 -4,733
　Disposal of Fixed Assets 11 52 59 4 68 388 1 25 6 63 9 6 16 0 0 0
　Increase in Investments 0 0 0 -1,422 -992 0 -8,352 0 0 0 -6,839 -399 -23,954 0 0 0
　Decrease in Investments 0 31,806 63,169 41,815 9,493 26,087 -285 0 0 0 0 0 0 0 0 0
　Net Cash Flow with Related Parties 0 0 0 0 0 0 0 0 0 0 0 0 -311 -6,632 -3,167 1,715
　Others 3,538 -2,551 10,708 -8,209 5,822 -16,138 -7,259 -1,755 -22,390 -5,877 -5,950 -7,998 29 5,836 7,541 -7,607
Net Cash Flow before Financing Activities 21,933 -37,693 93,934 37,685 12,355 7,389 -25,995 -3,102 -20,987 -16,923 -17,962 -17,299 -33,132 -4,416 3,370 -7,902
Net Cash Flow from Financing Activities -932 -13,505 -31,759 -28,757 -9,269 -9,055 17,793 7,047 25,854 16,311 13,668 17,319 43,783 -579 3,806 7,749
　New Loans 29,450 36,570 38,184 76,924 113,029 118,628 120,370 94,781 87,829 64,986 34,168 22,194 17,473 9,496 20,738 7,806
　Loans Repayment -34,368 -44,425 -69,943 -103,311 -122,295 -127,683 -102,577 -87,734 -61,975 -48,675 -20,500 -4,875 -26,374 -3,443 -13,765 -1,772
　Fixed Income/Debt Instruments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
　Equity Financing 7,618 0 0 0 0 0 0 0 0 0 0 0 52,995 0 0 0
　Net Cash Flow with Related Parties 0 0 0 0 0 0 0 0 0 0 0 0 -311 -6,632 -3,167 1,715
　Others -3,632 -5,650 0 -2,370 -3 0 0 0 0 0 0 0 0 0 0 0
Increase(Decrease) in Cash & Cash Equivalents 21,001 -51,198 62,175 8,928 3,086 -1,666 -8,202 3,945 4,867 -612 -4,294 20 10,651 -4,995 7,176 -153
Cash & Cash Equivalents at Beginning of Year 32,545 83,409 20,363 11,564 8,891 10,102 18,976 15,819 11,029 11,381 15,592 14,827 4,055 9,103 1,585 1,337
Net Cash Flow due to Change in Exchange Rate/Others -2,220 334 871 -129 -413 455 -672 -788 -77 260 83 745 121 -53 342 401
Cash & Cash Equivalents at End of Year 51,326 32,545 83,409 20,363 11,564 8,891 10,102 18,976 15,819 11,029 11,381 15,592 14,827 4,055 9,103 1,585
Currency U.S. Dollar U.S. Dollar U.S. Dollar U.S. Dollar U.S. Dollar U.S. Dollar U.S. Dollar U.S. Dollar U.S. Dollar U.S. Dollar U.S. Dollar U.S. Dollar U.S. Dollar U.S. Dollar U.S. Dollar U.S. Dollar
Unit Thousand Thousand Thousand Thousand Thousand
Auditor's Opinion 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.